Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ

NCT01501149 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Nasal and Nasal-type NK/T-cell Lymphoma

Interventions

DRUG: DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)
DRUG: Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）

Sponsor

Mingzhi Zhang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]